Answers are grounded in this paper and cite their sources.
Large loop excision of the transformation zone (LLETZ) is a common treatment for women who display grade 3 cervical intraepithelial neoplasia (CIN3). However, 78% of women report physical side effects and 71% of women report psychological effects after treatment. Furthermore, 76% of women report feeling rushed into the decision to undergo treatment, with no other monitoring option provided, highlighting the need for a less invasive monitoring procedure to be offered to patients. Long non-coding RNAs (LncRNAs) are non-coding RNA more than 200bp that display an abundance within serum. Previous research has associated the expression levels of several lncRNAs, such as Homeobox transcript antisense RNA (HOTAIR) and Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), with the commencement and progression of cervical cancer. This systematic review and meta-analysis aimed to evaluate the prognostic significance of HOTAIR and MALAT1 within the serum and tissue of cervical cancer patients. A literature search was conducted by three independent researchers spanning four databases. Using a PICOS inclusion and exclusion criteria, six identified studies (n=826) reported on the correlation between lncRNA expression and clinicopathological features in cervical cancer. HOTAIR or MALAT1 were significantly upregulated in cervical cancer patients compared to matched healthy participants (P = <0.001). Over-expression of HOTAIR or MALAT1 was associated with increased tumour size (odds ratio [OR] = 2.01, 95% confidence interval [CI] 1.42-2.85, P = <0.0.0001) and lymph node metastasis (OR = 5.32, 95% CI 3.26-8.69, P = <0.00001). Results showed that upregulation of HOTAIR or MALAT1 was associated with poorer overall survival (OS) (HOTAIR, OR = 5.73, 95% CI 3.37-9.74, P = <0.00001; MALAT1, OR = 4.00, 95% CI 2.10-7.63, P = <0.0001). High expression of HOTAIR or MALAT1 was also associated with decreased disease-free (DFS) or recurrence-free survival (RFS) (DFS, OR = 2.72 (95% CI 1.66-4.43, P = <0.0001; RFS, OR = 4.03, 95% CI 2.26-7.19, P = <0.00001). To conclude, HOTAIR and MALAT1 demonstrate potential as biomarkers for predicting the clinical outcomes and overall prognosis of cervical cancer patients. This could be a less invasive procedure option for women, to better inform patient autonomy prior to LLETZ procedure.
No takes yet. Share an insight, caveat, or question.
Wilkins et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: